byoRNA
Latest round
- Seed
Last raised
- Jul 2025
Total raised
- $1.8M
Investors
- 2
About byoRNA
byoRNA SAS, founded in 2022 in Pessac, France, focuses on the design and implementation of bioproduction platforms for mRNA production.ByoRNA specializes in the production of high-quality messenger RNA (mRNA) using proprietary bioproduction technology. Their offerings include designing and implementing bioproduction platforms that utilize eukaryotic cell biofactories to produce mRNA at lower costs compared to traditional methods. The technology allows for the extraction of highly purified therapeutic mRNA, addressing health challenges such as infectious diseases, cancer, and rare genetic disorders.ByoRNA generates revenue through partnerships with pharmaceutical and biotech companies seeking to utilize its mRNA production technology for therapeutic development. The transaction structure focuses on B2B collaborations, optimizing mRNA expression tailored to client needs. The company aims to expand into new markets across North America, Europe, and Asia by launching new products that address critical health challenges, enhancing its role in the mRNA landscape.
Who invested in byoRNA
2 investors across 1 round
See all investors in byoRNA
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jul 1, 2025
Amount
$1.8M
Investors
Questions about byoRNA
Who invested in byoRNA?
byoRNA has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has byoRNA raised?
byoRNA has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did byoRNA last raise money?
byoRNA's most recent round on record is a Seed, in Jul 2025.
What does byoRNA do?
byoRNA SAS, founded in 2022 in Pessac, France, focuses on the design and implementation of bioproduction platforms for mRNA production.
Where is byoRNA headquartered?
byoRNA is headquartered in Pessac, France.
Which VCs invest in companies like byoRNA?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at byoRNA's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like byoRNA? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.